Director and acting Chief Scientific Officer Nicole Steinmetz resigns, will remain as scientific advisor

Mosaic ImmunoEngineering Inc.

Nicole Steinmetz, Ph.D., resigned as director and acting CSO effective May 2, 2023.
Resignation not due to disagreement with company on operations, policies, or practices.
She will continue to serve as a scientific advisor to the Company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Nicole Steinmetz

Director and Acting Chief Scientific Officer

CPMV · Mosaic ImmunoEngineering Inc.

Effective: 2023-05-02
Filed: May 3, 2023, 7:59 PM ET

On May 2, 2023, Nicole Steinmetz, Ph.D., advised the board of directors of Mosaic ImmunoEngineering, Inc. (the “Company”) of her intention to resign as a member of the board of directors and acting Chief Scientific Officer effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nicole Steinmetz resigned as Director and Acting Chief Scientific Officer at Mosaic ImmunoEngineering Inc..

Action: resigned
Role: Director and Acting Chief Scientific Officer

Exact text from the filing

On May 2, 2023, Nicole Steinmetz, Ph.D., advised the board of directors of Mosaic ImmunoEngineering, Inc. (the “Company”) of her intention to resign as a member of the board of directors and acting Chief Scientific Officer effective immediately.

View on SEC.gov

Mosaic ImmunoEngineering Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-002890

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.